Investors

Press Releases

Press Releases

Jun 11, 2020
Data to be presented at the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II Cambridge, Mass. (June 11, 2020) – Kymera Therapeutics, Inc., a biotechnology company pioneering targeted protein degradation to invent breakthrough protein degrader medicines for patients,